logo
episode-header-image
Sep 10
20m 2s

Are We Curing Advanced Melanoma? A Conve...

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)
About this episode

Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 survival data, safer immunotherapy dosing, and the rise of neoadjuvant treatment.

LINK TO FULL TRANSCRIPT

 

Up next
Sep 3
Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities
Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing toxicities in clinical practice. ... Show More
23m 1s
Aug 20
How Do We Translate ASCO26 Research Into Practice in Latin America?
In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges ... Show More
21m 36s
Aug 6
GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?
Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials. LINK TO FULL TRANSCRIPT 
18m 15s
Recommended Episodes
Jul 2024
Ep. 178 ASCO 2024: Game-Changing GU Oncology Updates in Bladder and Kidney Cancers with Dr. Sumanta Pal and Dr. Petros Grivas
Stay up-to-date on the latest advancements and treatment strategies in the field of genitourinary oncology. In this episode of BackTable Urology, guest host Dr. Bogdana Schmidt, a urologic oncologist from the University of Utah, discusses takeaways from ASCO 2024 with Dr. Petros ... Show More
57m 23s
Oct 2025
Ep. 267 Sequencing Therapies in NMIBC Management with Dr. Mark Tyson and Dr. Suzanne Merrill
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ... Show More
1 h
Aug 2024
S2 Episode 5: Adjuvant Chemo in Colorectal Cancer: What's Working Now?
Join Drs Benjamin Schlechter and Jeff Meyerhardt as they discuss the latest breakthroughs in adjuvant chemo for CRC and share their decision-making in real-world scenarios. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ... Show More
24m 52s
Aug 2023
Immunotherapy in TNBC: What's New, What's Next?
Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991253). The ... Show More
20m 52s
Dec 2023
Thinking Beyond TROP2 at ESMO 2023
What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991259). The topics and dis ... Show More
17m 6s
Oct 2025
Ep. 245 Understanding Keynote-689: Immunotherapy for Head & Neck Cancer with Dr. Dylan Roden, Dr. Ravi Uppaluri and Dr. Adam Luginbuhl
While the standard for adjuvant head and neck cancer treatment hasn't changed since 2004, a new trial using perioperative pembrolizumab is forcing clinicians to rethink their entire workflow, starting with diagnosis. In this episode of the BackTable Podcast, head and neck surgica ... Show More
40m 45s
Dec 2024
2024 State of Lung Cancer: The Hopes and Hurdles of Precision Oncology with Dr. Jacob Sands
For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ... Show More
33m 9s
Sep 2020
Immunotherapy: Transforming How Cancers Are Treated
In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ... Show More
23m 44s
Oct 2023
S1 Episode 6: Systemic Therapy for Advanced Colorectal Cancer
Join experts Drs Benjamin Schlechter and Diane Saverese as they discuss systemic therapy for advanced colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/988974). The topics and discussions are planned ... Show More
23m 2s
Jun 2023
Highlights From the 2023 American Society of Clinical Oncology Annual Meeting
<p>JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.<br /> <br /> <strong>Rela ... Show More
21m 41s